Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
BlackRock Inc.
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 6,526,588 | 387,524 | 165,187,942,000 | -32,551,312,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 6,139,064 | 7,248 | 197,739,254,000 | 197,573,695,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 6,131,816 | 446,985 | 165,559,000 | 86,995,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 5,684,831 | 397,683 | 78,564,000 | -24,537,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 5,287,148 | -46,951 | 103,101,000 | 16,049,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 5,334,099 | -37,368 | 87,052,000 | -62,597,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 5,371,467 | 23,789 | 149,649,000 | -8,857,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 5,347,678 | -46,161 | 158,506,000 | 7,748,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 5,393,839 | 381,487 | 150,758,000 | 8,707,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 5,012,352 | 131,164 | 142,051,000 | 19,338,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 4,881,188 | 441,988 | 122,713,000 | 14,307,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 4,439,200 | 431,821 | 108,406,000 | 49,097,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 4,007,379 | 318,722 | 59,309,000 | -559,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,688,657 | 122,686 | 59,868,000 | 13,511,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,565,971 | 37,912 | 46,357,000 | 46,311,241 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,528,059 | -22,079 | 45,759 | -55,905,241 | $0.01 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,550,138 | 343,538 | 55,951,000 | -8,598,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,206,600 | 11,617 | 64,549,000 | -14,846,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,194,983 | 263,003 | 79,395,000 | -1,087,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 2,931,980 | 521,536 | 80,482,000 | 6,239,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 2,410,444 | 242,233 | 74,243,000 | -3,270,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 2,168,211 | 2,611 | 77,513,000 | 17,851,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 2,165,600 | 117,546 | 59,662,000 | 17,062,000 | $27.55 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 2,048,054 | 2,046,647 | 42,600,000 | 42,570,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 1,407 | -217 | 30,000 | 4,000 | $21.32 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 1,624 | 1,624 | 26,000 | 26,000 | $16.01 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 1,893 | 423 | 26,000 | 1,000 | $13.73 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 1,470 | 1,102 | 25,000 | 12,000 | $17.01 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 368 | 0 | 13,000 | 2,000 | $35.33 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 368 | 0 | 11,000 | -1,000 | $29.89 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 368 | 103 | 12,000 | 7,000 | $32.61 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 265 | 0 | 5,000 | 1,000 | $18.87 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 265 | 89 | 4,000 | 1,000 | $15.09 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 176 | 0 | 3,000 | -3,000 | $17.05 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 176 | 176 | 6,000 | 6,000 | $34.09 |
| << Prev Next >> |
|